Camallergy's Angel Round

Camallergy raised a round of funding on December 08, 2017.

Camallergy is a drug development company. Camallergy's lead product, CA002, is an oral immunotherapy drug which desensitizes patients by gradual exposure to increasing amounts of characterized peanut …

Articles about Camallergy's Angel Round: